Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective is to assess the long term safety of administration of lanreotide Autogel 120 mg every 28 days in patients with non functioning entero-pancreatic neuro endocrine tumour.
Inclusion criteria
- Non functioning entero-pancreatic tumour